Page 25 - Pharma Plc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Nanoform and Herantis partner to look for opportunities to enhance BBB penetration of CDNF and xCDNF molecules Nanoform Inside information December 17, 2020 at 7:15 p.m. Finnish time Nanoform and Herantis partner to look for opportunities to enhance BBB penetration of CDNF and xCDNF molecules Helsinki, Finland – Nanoform Finland Plc, an innovative nanoparticle medicine enabling company, and Herantis Pharma Plc, an innovative drug development company, today announced that they have signed a letter of intent to collaborate to seek to enhance nasal drug delivery to the brain of Herantis’ CD...

Share this article Share this article ResearchAndMarkets.com's offering. The report gives insights into the transformational microbiome landscape. It is a rigorous assessment of the industry trends supported by detailed segmentation across publications, grants, clinical trials, and startup funding activity. The dataset behind the report is based on real world evidence that will drive actionable business insights. Follow trends over the years captured across publications, grants, clinical trials, and startup funding activity to power data driven marketing campaigns to fund raising to investo...